Safety of the combination of intensive cholesterol-lowering therapy with oral anticoagulation medication in elderly patients with atrial fibrillation: a randomized, double-blind, placebo-controlled study.

Enajat, Morteza; Teerenstra, Steven; van Kuilenburg, Janet T; van Sorge-Greve, Aty H N; Albers-Akkers, Marjo T H; Verheugt, Freek W A; Pop, Gheorghe A M

Enajat, Morteza; Teerenstra, Steven; van Kuilenburg, Janet T; van Sorge-Greve, Aty H N; Albers-Akkers, Marjo T H; Verheugt, Freek W A; Pop, Gheorghe A M.

Affiliation

Enajat M; Heart Centre, St Radboud University Medical Centre, Nijmegen, the Netherlands. m.enajat@live.nl

Drugs Aging ; 26(7): 585-93, 2009.

Article in En | MEDLINE | ID: mdl-19655825

Subject(s)

Anticholesteremic Agents/administration & dosage; Anticholesteremic Agents/adverse effects; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Atrial Fibrillation/drug therapy; Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents/administration & dosage; Anti-Inflammatory Agents/adverse effects; Atrial Fibrillation/complications; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Endpoint Determination; Female; Hemorrhage/etiology; Humans; Male; Medication Adherence; Placebo Effect

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Anticholesteremic Agents / Anticoagulants Type of study: Clinical_trials / Etiology_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Drugs Aging Journal subject: GERIATRIA / TERAPIA POR MEDICAMENTOS Year: 2009 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google